Allogeneic stem cell transplantation after nonmyeloablative regimen is feasible and efficient in old patients with refractory or relapsing acute leukemia.
Jost, E., Sonet, A., Doyen, C., Robin, V., Van Houte, B., Maerevoet, M., Osselaer, J.-C., Chatelain, C., Chatelain, B., & Bosly, A. (1998). Allogeneic stem cell transplantation after nonmyeloablative regimen is feasible and efficient in old patients with refractory or relapsing acute leukemia. Blood, 92(10), 351B-351B. (Original work published 1998)